FDA Inspection 1150114 — ADMA Biologics, Inc

ADMA Biologics, Inc — FEI 1000525461

The FDA completed an inspection of ADMA Biologics, Inc on Aug 12, 2021 in Boca Raton, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 12, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boca Raton, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.